Ludwig Cancer Research Institute, an international community of scientists focused on cancer research, with headquarters in New York City, NY and Zürich, Switzerland, have uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

Lead Research/Investigator

Ping-Chih Ho
Source: Onconzine

Pin It on Pinterest